Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer. / Afzal, Shoaib; Bojesen, Stig E; Nordestgaard, Børge G.

I: Clinical Chemistry, Bind 59, Nr. 5, 2013, s. 771-780.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Afzal, S, Bojesen, SE & Nordestgaard, BG 2013, 'Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer', Clinical Chemistry, bind 59, nr. 5, s. 771-780. https://doi.org/10.1373/clinchem.2012.201939

APA

Afzal, S., Bojesen, S. E., & Nordestgaard, B. G. (2013). Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer. Clinical Chemistry, 59(5), 771-780. https://doi.org/10.1373/clinchem.2012.201939

Vancouver

Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer. Clinical Chemistry. 2013;59(5):771-780. https://doi.org/10.1373/clinchem.2012.201939

Author

Afzal, Shoaib ; Bojesen, Stig E ; Nordestgaard, Børge G. / Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer. I: Clinical Chemistry. 2013 ; Bind 59, Nr. 5. s. 771-780.

Bibtex

@article{f9dc16cd278946558e41b489a4183650,
title = "Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer",
abstract = "Tobacco smoke chemicals may influence vitamin D metabolism and function, and conversely vitamin D may modify the carcinogenicity of tobacco smoke chemicals. We tested the hypothesis that lower plasma 25-hydroxyvitamin D [25(OH)D] is associated with a higher risk of tobacco-related cancer in the general population.",
author = "Shoaib Afzal and Bojesen, {Stig E} and Nordestgaard, {B{\o}rge G}",
year = "2013",
doi = "10.1373/clinchem.2012.201939",
language = "English",
volume = "59",
pages = "771--780",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Low plasma 25-hydroxyvitamin d and risk of tobacco-related cancer

AU - Afzal, Shoaib

AU - Bojesen, Stig E

AU - Nordestgaard, Børge G

PY - 2013

Y1 - 2013

N2 - Tobacco smoke chemicals may influence vitamin D metabolism and function, and conversely vitamin D may modify the carcinogenicity of tobacco smoke chemicals. We tested the hypothesis that lower plasma 25-hydroxyvitamin D [25(OH)D] is associated with a higher risk of tobacco-related cancer in the general population.

AB - Tobacco smoke chemicals may influence vitamin D metabolism and function, and conversely vitamin D may modify the carcinogenicity of tobacco smoke chemicals. We tested the hypothesis that lower plasma 25-hydroxyvitamin D [25(OH)D] is associated with a higher risk of tobacco-related cancer in the general population.

U2 - 10.1373/clinchem.2012.201939

DO - 10.1373/clinchem.2012.201939

M3 - Journal article

C2 - 23503722

VL - 59

SP - 771

EP - 780

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 5

ER -

ID: 48538759